Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Melatonin pathway genes are associated with progressive subtypes and disability status in multiple sclerosis among Finnish patients.
The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy.
Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment.
Exome sequencing in single cells from the cerebrospinal fluid in multiple sclerosis.
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis.
Humoral immune response to influenza vaccine in natalizumab-treated MS patients.
Anti-JC virus seroprevalence in a Finnish MS cohort.
Riluzole enhances glutamate uptake in rat astrocyte cultures.
Effects of dual-task balance training on postural performance in patients with Multiple Sclerosis: A double-blind, randomized controlled pilot trial.
Can smoking aggravate my multiple sclerosis symptoms?
Serum level of interleukin-6 in Chinese patients with multiple sclerosis.
Importance of Human Leukocyte Antigen (HLA) Class I and II Alleles on the Risk of Multiple Sclerosis.
Biogen Idec to present new two-year data from the PLEGRIDY™ (peginterferon beta-1a) Phase III advance study at AAN annual meeting
The refinement of genetic predictors of multiple sclerosis.
Olfactory dysfunction in multiple sclerosis.
The role of microbiome in central nervous system disorders.
Preventive healthcare use among males with multiple sclerosis.
A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic.
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
Multiple sclerosis and pain.
The nocebo effect: A clinicians guide.
Natalizumab-induced autoimmune hepatitis in a patient with multiple sclerosis.
T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
Central Nervous System and its Disease Models on a Chip.
Superficial spreading malignant melanoma in a patient on fingolimod therapy for multiple sclerosis.

Pages